3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
33
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma
19
Myelodysplastic Syndromes
16
Hodgkin Disease
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
10
Leukemia, Myeloid, Acute
10
Lymphoma, Non-Hodgkin
8
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
7
Recurrence
6
Myeloproliferative Disorders
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Chronic-Phase
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
4
Neoplasms, Plasma Cell
4
Lymphoma, T-Cell, Cutaneous
4
Congenital Abnormalities
4
Burkitt Lymphoma
4
Anemia, Aplastic
4
Sezary Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic-Myeloproliferative Diseases
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Large-Cell, Immunoblastic
3
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Alemtuzumab
×
Clear all
No trials found.